The hedge fund run by Martin Hughes held 1.35 million shares of the major banks company at the end of 2017Q4, valued at $43.20M, up from 1.28 million at the end of the previous reported quarter. The stock increased 0.02% or $0.01 during the last trading session, reaching $56.9. M&R Capital Management Inc. now owns 1,550 shares of the healthcare conglomerate's stock valued at $299,000 after purchasing an additional 200 shares during the last quarter.
Analysts await Cabot Corporation (NYSE:CBT) to report earnings on May, 7 after the close. It has underperformed by 17.46% the S&P500.
Christopher Medlock James increased its stake in Unitedhealth Group Inc (UNH) by 22.07% based on its latest 2017Q4 regulatory filing with the SEC. Pettee Invsts Inc invested in 0.42% or 3,120 shares. The institutional investor held 46,855 shares of the medical specialities company at the end of 2017Q4, valued at $10.33 million, up from 42,550 at the end of the previous reported quarter. Unitedhealth Group Inc now has $228.09 billion valuation. The stock decreased 0.20% or $0.48 during the last trading session, reaching $238.07. About 575,201 shares traded. Altria Group, Inc. (NYSE:MO) has declined 17.05% since April 19, 2017 and is downtrending. It has outperformed by 20.87% the S&P500.
Investors sentiment decreased to 1.24 in 2017 Q4. Its up 0.05, from 0.91 in 2017Q3. 162 funds opened positions while 585 raised stakes. The company's last traded volume of 2.94 million shares was up it's an average volume of 4.01 million shares.
The short ratio in the company's stock is documented at 2.10 and the short float is around of 0.88%. (NYSE:MO) on Monday, July 17 with "Hold" rating. Macquarie Grp Limited holds 26,400 shares or 0% of its portfolio. Centurylink Investment accumulated 11,418 shares. Following the transaction, the director now directly owns 76,637 shares of the company's stock, valued at $18,881,824.06. M&T Bank reported 0.01% in Boston Scientific Corporation (NYSE:BSX). Ubs Asset Management Americas invested in 0.02% or 180,598 shares. Corporate insiders own 0.89% of the company's stock. The institutional investors in our database now have: 10.63 million shares, up from 9.91 million shares in 2017Q3. 23,298 were reported by Clinton Gru. 5,772 were reported by Stewart Patten Limited Liability Co. Fort Washington Investment Oh has 3.88 million shares for 1.14% of their portfolio. Coldstream Capital Management Inc. now owns 1,698 shares of the healthcare conglomerate's stock worth $315,000 after acquiring an additional 466 shares during the period.
Since October 30, 2017, it had 0 buys, and 15 selling transactions for $7.82 million activity. 5,820 shares valued at $1.40M were sold by WILENSKY GAIL R on Thursday, January 18. $399,865 worth of Boston Scientific Corporation (NYSE:BSX) shares were sold by Phalen Michael P. On Monday, March 5 Sorenson John Bradley sold $53,496 worth of Boston Scientific Corporation (NYSE:BSX) or 1,950 shares. BURKE RICHARD T sold $2.24M worth of stock. 85,227 Boston Scientific Corporation (NYSE:BSX) shares with value of $2.26 million were sold by Fitzgerald Joseph Michael. Bainco Invsts invested in 1.46% or 52,602 shares.
Among 26 analysts covering UnitedHealth Group (NYSE:UNH), 26 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Boston Scientific Corporation had 92 analyst reports since July 27, 2015 according to SRatingsIntel. MO's profit will be $1.78B for 16.36 P/E if the $0.94 EPS becomes a reality. JPMorgan Chase increased their price objective on UnitedHealth Group to $266.00 and gave the stock an "overweight" rating in a research report on Wednesday. On Wednesday, July 19 the stock rating was maintained by Barclays Capital with "Overweight". The target price by Credit Suisse would suggest a potential upside of 14.64 % from the company's last price. On Wednesday, December 6 the stock rating was maintained by Cantor Fitzgerald with "Buy".
Recently, In an analyst note revealed to clients and investors on Monday, 25 December, UnitedHealth (NYSE:UNH) shares have had their "Buy" Rating reconfirmed by research analysts at Cantor Fitzgerald, who now has a $235.0 TP on company. The rating was maintained by Jefferies with "Buy" on Wednesday, June 21. It also reduced its holding in State Str Corp Com (NYSE:STT) by 171,523 shares in the quarter, leaving it with 227,490 shares, and cut its stake in Nvr Inc (NYSE:NVR).
During Q4 2017 the big money sentiment increased to 0.96. It is positive, as 51 investors sold UNH shares while 538 reduced holdings. 138 funds bought positions and 426 increased positions. The healthcare conglomerate reported $3.04 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $2.91 by $0.13. First Commonwealth Pa owns 0.24% invested in UnitedHealth Group Incorporated (NYSE:UNH) for 1,038 shares. Dorsey Whitney Tru Comm Ltd Liability Company stated it has 0.68% of its portfolio in UnitedHealth Group Incorporated (NYSE:UNH). Kentucky Retirement Insur Trust Fund stated it has 0.95% in UnitedHealth Group Incorporated (NYSE:UNH). Spirit Of America Mgmt invested in 9,500 shares. L & S Advisors, a California-based fund reported 11,842 shares. New York-based Contour Asset Lc has invested 8.42% in Marvell Technology Group Ltd. (NASDAQ:MRVL). Caisse De Depot Et Placement Du Quebec reported 2.75M shares. Kornitzer Cap Ks holds 223,148 shares or 0.54% of its portfolio. UnitedHealth Group Incorporated (NYSE:UNH) has risen 32.42% since April 19, 2017 and is uptrending. Landscape Capital accumulated 1,628 shares. Meeder Asset Mgmt invested 0.7% in UnitedHealth Group Incorporated (NYSE:UNH). Finally, Osborn Williams & Donohoe LLC boosted its holdings in shares of UnitedHealth Group by 1.6% during the fourth quarter.
Since October 19, 2017, it had 0 insider buys, and 10 sales for $29.08 million activity. Finally, Piper Jaffray reaffirmed a buy rating and set a $259.00 target price on shares of UnitedHealth Group in a research report on Wednesday, January 17th. On Wednesday, January 31 HOOPER MICHELE J sold $2.38M worth of UnitedHealth Group Incorporated (NYSE:UNH) or 10,000 shares. Another trade for 975 shares valued at $200,333 was made by ROOS THOMAS E on Thursday, October 19.
- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
- Swaziland king changes country's name to Kingdom of eSwatini
- Alabama and Notre Dame Agree to Home-and-Home Series
- Introducing Verizon Smart Family
- What we learned from Game 4: Predators 3, Avalanche 2
- MACOM Technology Solutions (MTSI) Trading Up 7.3%
- Barclays Analysts Give Macquarie Infrastructure (MIC) a $41.00 Price Target
- Israel 'Struck Advanced Iranian Air-defense System' in Syria
- Alex Rodriguez's Nephew Kidnapped, Held for Ransom in Botched Lamborghini Deal
- Jaguar introduced the new modification of the sedan XE and XF
- National guardsmen who made viral dinosaur video face serious punishment